Neurodegenerative Drugs Market Growth Rate And Industry Analysis 2022-2028

The Neurodegenerative Drugs Market is segmented, By Type (N-Methyl-D-Aspartic Acid (NMDA), Selective Serotonin Reuptake Inhibitors (SSRIs), Dopamine Inhibitors, Other), Disease Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer's Disease, Spinal Muscular Atrophy (SMA), Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), and Region - (North America, Europe, Asia-Pacific, and Rest of the World).

What is neurodegenerative disease?

Neurodegenerative disease is defined as a group of diseases that affects the neurons in the human brain. The inability of neurons to reproduce themselves results in the development of neurodegenerative diseases. Neurodegenerative diseases include multiple sclerosis, Parkinson's disease, Alzheimer's disease, spinal muscular atrophy (SMA), and others.

Key Players

Key players operating in the neurodegenerative drugs market are-

• Novartis International AG (Switzerland)
• Pfizer Inc. (US)
• Merck Serono (Germany)
• Biogen Inc. (US)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Benetton Group S.r.l. (Italy)
• C.H. Boehringer Sohn AG & Ko. KG (Germany)
• Sanofi S.A. (France)
• GlaxoSmithKline plc (UK).

Market Dynamics

The growth of the neurodegenerative drugs market is primarily driven by the increasing prevalence of Alzheimer's and Parkinson's diseases. Expanding the geriatric populace across geographies is likely to drive market growth at a significant rate during the review period. In addition to this, increasing investment in research and development activities to develop new treatment methods is likely to create lucrative opportunities for the players operating in the global neurodegenerative drugs market in the coming years.

Want to get know more about this report, Click here: https://www.stratviewresearch.com/2299/Neurodegenerative-Drugs-Market.html

Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, or to cover analysis on any particular geography or segment, please send your inquiry at sales@stratviewresearch.com or +1-313-307-4176.

What we do –

Stratview Research is a growing market research firm. Experts here illustrate innovative, descriptive, and comprehensive insights through market research to satisfy your individual and organizational objectives. We assist the users to make well-informed, profound and favourable decisions to comprehend the advantages of forthcoming trends, developments, assessments, and opportunities through our precise understanding of the market.

Article source: https://article-realm.com/article/Finance/32993-Neurodegenerative-Drugs-Market-Growth-Rate-And-Industry-Analysis-2022-2028.html